Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Fumito Ito, MD, PhD

Photo of Fumito Ito, MD, PhD
Title(s)Professor of Surgery and Molecular Microbiology and Immunology
SchoolKeck School of Medicine of Usc
Address1520 San Pablo St.
Health Sciences Campus
Los Angeles CA 90033
ORCID ORCID Icon0000-0002-6866-671X Additional info
vCardDownload vCard
    Other Positions
    Title(s)Co-Leader of the Translational and Clinical Sciences Research (TACS) Program


    Collapse Biography 
    Collapse education and training
    University of Michigan, Ann Arbor, MIResearch Fellowship06/2003Tumor Immunology
    University of Wisconsin, Madison, WIResidency06/2008Surgery
    Roswell Park Comprehensive Cancer Center, Buffalo, NYClinical Fellowship06/2010Surgical Oncology

    Collapse Overview 
    Collapse webpage

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Facilitators and Barriers to the Timely Diagnosis and Treatment of Melanoma in Latino Persons. JAMA Dermatol. 2025 Dec 01; 161(12):1224-1228. Miller KA, Marìn P, Aguero R, Muñoz G, Caldera M, Unger JB, Crew AB, Ito F, Baezconde-Garbanati L, Cockburn MG. PMID: 41032320; PMCID: PMC12489795.
      View in: PubMed   Mentions:
    2. The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee. J Immunother Cancer. 2025 Nov 29; 13(11). Coukos G, Donia M, Gastman BR, Goff SL, Gros A, Harari A, Hernandez S, Ito F, Maker AV, Mullinax JE, Murthy P, Pai SI, Prabhakaran S, Restifo NP, Silver NL, Marincola Smith P, Turcotte S, Wagner PL, Yang JC, Lotze MT. PMID: 41320228.
      View in: PubMed   Mentions:
    3. Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients. J Surg Oncol. 2025 Oct; 132(5):853-859. Brabender DE, Griffiths A, Lu KA, Armstrong K, Nelson ME, Ito F, Carr AA, Siegel EL, Sener SF. PMID: 40838899; PMCID: PMC12501913.
      View in: PubMed   Mentions:    Fields:    
    4. Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non-Small Cell Lung Cancer Patients. Cancer Res Commun. 2025 Jul 01; 5(7):1082-1094. Polyakov L, Lim A, Meyer A, Mades A, Ni J, Cooper R, Ye S, Kajihara R, Oba T, Contreras L, Abdelfatah E, Sarkar J, Matsuzaki J, Li M, Sharma R, Segal BH, Hsu RC, Chen H, Nieva J, Ito F. PMID: 40622275; PMCID: PMC12232904.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma. Pigment Cell Melanoma Res. 2025 May; 38(3):e70027. Wang SJ, Xiu J, Butcher KM, DeClerck BK, Kim GH, Moser J, Gibney GT, Hernandez-Aya LF, Lutzky J, Abdulla F, Margolin KA, Possik PA, Robles-Espinoza CD, Ito F, In GK. PMID: 40405404; PMCID: PMC12099029.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy. J Immunother Cancer. 2025 Jan 25; 13(1). Kajihara R, Long MD, Hoki T, Chen H, Yamauchi T, Kanemaru H, Segal BH, Dy GK, Ito F. PMID: 39863301; PMCID: PMC11784231.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    7. Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanoma. Br J Dermatol. 2025 Jan 24; 192(2):316-326. McGillivray E, Ashouri K, Chatziioannou E, Gallegos JAO, Zarka J, Kechter J, Hwang AS, Zhang K, Barros M, Yeh J, Okazaki I, Crocker AB, Maeda T, Park SJ, Choi J, Andreoli M, Darwish T, Savage DJ, Kim KB, Gupta J, Shen J, Shirai K, Choi A, Pai L, Vazquez VL, Moser J, Amaral T, Hernandez Aya LF, Lutzky J, Najjar YG, Costello CM, Mangold AR, Bhatia S, Gibney GT, Farma JM, Daniels GA, Sosman J, Chandra S, Mangla A, Bollin K, Possik PA, Robles-Espinoza CD, Ito F, In GK. PMID: 39438074; PMCID: PMC11758508.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Generation, Transcriptomic States, and Clinical Relevance of CX3CR1+ CD8 T Cells in Melanoma. Cancer Res Commun. 2024 07 01; 4(7):1802-1814. Ishigaki H, Yamauchi T, Long MD, Hoki T, Yamamoto Y, Oba T, Ito F. PMID: 38881188; PMCID: PMC11267618.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    9. Innate and adaptive immune cell interaction drives inflammasome activation and hepatocyte apoptosis in murine liver injury from immune checkpoint inhibitors. Cell Death Dis. 2024 02 14; 15(2):140. Shojaie L, Bogdanov JM, Alavifard H, Mohamed MG, Baktash A, Ali M, Mahov S, Murray S, Kanel GC, Liu ZX, Ito F, In GK, Merchant A, Stohl W, Dara L. PMID: 38355725; PMCID: PMC10866933.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    10. Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma. Sci Rep. 2024 01 29; 14(1):2394. Oba T, Long MD, Ito KI, Ito F. PMID: 38287061; PMCID: PMC10825192.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    11. Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases. NPJ Precis Oncol. 2023 Nov 14; 7(1):120. In GK, Ribeiro JR, Yin J, Xiu J, Bustos MA, Ito F, Chow F, Zada G, Hwang L, Salama AKS, Park SJ, Moser JC, Darabi S, Domingo-Musibay E, Ascierto ML, Margolin K, Lutzky J, Gibney GT, Atkins MB, Izar B, Hoon DSB, VanderWalde AM. PMID: 37964004; PMCID: PMC10646102.
      View in: PubMed   Mentions: 13  
    12. Fluctuations in Gut Microbiome Composition During Immune Checkpoint Inhibitor Therapy. World J Oncol. 2023 Jun; 14(3):178-187. Sarkar J, Cortes Gomez E, Oba T, Chen H, Dy GK, Segal BH, Ernstoff MS, Ito F. PMID: 37350807; PMCID: PMC10284636.
      View in: PubMed   Mentions: 5  
    13. Predictive and Prognostic Implications of Circulating CX3CR1+ CD8+ T Cells in Non-Small Cell Lung Cancer Patients Treated with Chemo-Immunotherapy. Cancer Res Commun. 2023 03; 3(3):510-520. Abdelfatah E, Long MD, Kajihara R, Oba T, Yamauchi T, Chen H, Sarkar J, Attwood K, Matsuzaki J, Segal BH, Dy GK, Ito F. PMID: 37009132; PMCID: PMC10060186.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    14. Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center. J Surg Oncol. 2023 Jul; 128(1):9-15. Sargent RE, Siegel E, Ito F, Kramme K, Kraft E, Hendrix V, Carr AA, Nelson ME, Bian SX, Jayachandran P, Sener SF. PMID: 36933187.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    15. Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction. Cancer Immunol Immunother. 2022 Dec; 71(12):2881-2898. Zangari B, Tsuji T, Matsuzaki J, Mohammadpour H, Eppolito C, Battaglia S, Ito F, Chodon T, Koya R, Robert McGray AJ, Odunsi K. PMID: 35460379; PMCID: PMC9588092.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    16. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling. J Immunother Cancer. 2022 01; 10(1). Makino K, Long MD, Kajihara R, Matsueda S, Oba T, Kanehira K, Liu S, Ito F. PMID: 35101945; PMCID: PMC8804689.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    17. Immunization with short peptide particles reveals a functional CD8+ T-cell neoepitope in a murine renal carcinoma model. J Immunother Cancer. 2021 12; 9(12). He X, Zhou S, Dolan M, Shi Y, Wang J, Quinn B, Jahagirdar D, Huang WC, Tsuji M, Pili R, Ito F, Ortega J, Abrams SI, Ebos JML, Lovell JF. PMID: 34862254; PMCID: PMC8647534.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    18. Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer. Sci Rep. 2021 11 09; 11(1):21992. Yokoi T, Oba T, Kajihara R, Abrams SI, Ito F. PMID: 34754037; PMCID: PMC8578367.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    19. Position-Scanning Peptide Libraries as Particle Immunogens for Improving CD8+ T-Cell Responses. Adv Sci (Weinh). 2021 12; 8(24):e2103023. He X, Zhou S, Quinn B, Huang WC, Jahagirdar D, Vega M, Ortega J, Long MD, Ito F, Abrams SI, Lovell JF. PMID: 34716694; PMCID: PMC8693074.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    20. Neoadjuvant In Situ Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic Tumors. Cancer Res. 2021 12 15; 81(24):6183-6195. Oba T, Kajihara R, Yokoi T, Repasky EA, Ito F. PMID: 34666993; PMCID: PMC8678344.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    21. Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 Expression. J Immunol. 2021 09 01; 207(5):1298-1309. Patel A, Oba T, Kajihara R, Yokoi T, Abrams SI, Ito F. PMID: 34362833; PMCID: PMC8387427.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    22. Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis. J Immunother Cancer. 2021 06; 9(6). Puzanov I, Subramanian P, Yatsynovich YV, Jacobs DM, Chilbert MR, Sharma UC, Ito F, Feuerstein SG, Stefanovic F, Switzer B, Hicar MD, Curtis AB, Spangenthal EJ, Dy GK, Ernstoff MS, Vachhani P, Page BJ, Agrawal N, Khunger A, Kapoor A, Hattoum A, Schentag JJ. PMID: 34162715; PMCID: PMC8231054.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    23. CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells. Cancer Immunol Immunother. 2022 Jan; 71(1):137-151. Yamauchi T, Hoki T, Oba T, Kajihara R, Attwood K, Cao X, Ito F. PMID: 34037810; PMCID: PMC8715856.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCellsPHPublic Health
    24. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models. J Immunother Cancer. 2021 05; 9(5). Oba T, Makino K, Kajihara R, Yokoi T, Araki R, Abe M, Minderman H, Chang AE, Odunsi K, Ito F. PMID: 34049930; PMCID: PMC8166607.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    25. T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors. Nat Commun. 2021 03 03; 12(1):1402. Yamauchi T, Hoki T, Oba T, Jain V, Chen H, Attwood K, Battaglia S, George S, Chatta G, Puzanov I, Morrison C, Odunsi K, Segal BH, Dy GK, Ernstoff MS, Ito F. PMID: 33658501; PMCID: PMC7930182.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimalsCells
    26. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee. J Immunother Cancer. 2020 11; 8(2). Gastman B, Agarwal PK, Berger A, Boland G, Broderick S, Butterfield LH, Byrd D, Fecci PE, Ferris RL, Fong Y, Goff SL, Grabowski MM, Ito F, Lim M, Lotze MT, Mahdi H, Malafa M, Morris CD, Murthy P, Neves RI, Odunsi A, Pai SI, Prabhakaran S, Rosenberg SA, Saoud R, Sethuraman J, Skitzki J, Slingluff CL, Sondak VK, Sunwoo JB, Turcotte S, Yeung CC, Kaufman HL. PMID: 33199512; PMCID: PMC7670953.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    27. Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s. Nat Commun. 2020 10 27; 11(1):5415. Oba T, Long MD, Keler T, Marsh HC, Minderman H, Abrams SI, Liu S, Ito F. PMID: 33110069; PMCID: PMC7592056.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    28. A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells. J Immunol. 2020 10 01; 205(7):1867-1877. Oba T, Hoki T, Yamauchi T, Keler T, Marsh HC, Cao X, Ito F. PMID: 32848036; PMCID: PMC7511447.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    29. CX3CR1-CD8+ T cells are critical in antitumor efficacy but functionally suppressed in the tumor microenvironment. JCI Insight. 2020 04 23; 5(8). Yamauchi T, Hoki T, Oba T, Saito H, Attwood K, Sabel MS, Chang AE, Odunsi K, Ito F. PMID: 32255766; PMCID: PMC7205436.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    30. In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy. Int J Hyperthermia. 2019 11; 36(sup1):22-36. Ito F, Vardam TD, Appenheimer MM, Eng KH, Gollnick SO, Muhitch JB, Evans SS. PMID: 31795828; PMCID: PMC6897324.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    31. Induced Pluripotent Stem Cell-Derived T Cells for Cancer Immunotherapy. Surg Oncol Clin N Am. 2019 07; 28(3):489-504. Patel SJ, Yamauchi T, Ito F. PMID: 31079802; PMCID: PMC6516087.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    32. Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma. J Surg Res. 2019 02; 234:343-352. Hoki T, Katsuta E, Yan L, Takabe K, Ito F. PMID: 30527495; PMCID: PMC6291835.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    33. Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System. Cell Rep. 2018 03 20; 22(12):3175-3190. Vizcardo R, Klemen ND, Islam SMR, Gurusamy D, Tamaoki N, Yamada D, Koseki H, Kidder BL, Yu Z, Jia L, Henning AN, Good ML, Bosch-Marce M, Maeda T, Liu C, Abdullaev Z, Pack S, Palmer DC, Stroncek DF, Ito F, Flomerfelt FA, Kruhlak MJ, Restifo NP. PMID: 29562175; PMCID: PMC5930030.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    34. Emerging role of RNA binding protein UNR/CSDE1 in melanoma. J Xiangya Med. 2017 May; 2. Gandhi S, Ito F, Ernstoff MS. PMID: 30135958; PMCID: PMC6100785.
      View in: PubMed   Mentions:
    35. Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes. J Vis Exp. 2016 11 11; (117). Saito H, Iwabuchi K, Fusaki N, Ito F. PMID: 27911363; PMCID: PMC5226217.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    36. Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological Memory. Cancer Res. 2016 06 15; 76(12):3473-83. Saito H, Okita K, Chang AE, Ito F. PMID: 27197199; PMCID: PMC4911287.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    37. Pre-resectional Radiofrequency Ablation as a Neoadjuvant in situ Tumor Vaccine. J Vaccines Vaccin. 2016 Apr; 7(2). Ito F, Evans SS. PMID: 28944091; PMCID: PMC5606234.
      View in: PubMed   Mentions: 2  
    38. Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells. Stem Cells Int. 2016; 2016:8394960. Saito H, Okita K, Fusaki N, Sabel MS, Chang AE, Ito F. PMID: 27057178; PMCID: PMC4707343.
      View in: PubMed   Mentions: 15  
    39. Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer. PLoS One. 2015; 10(11):e0143370. Ito F, Ku AW, Bucsek MJ, Muhitch JB, Vardam-Kaur T, Kim M, Fisher DT, Camoriano M, Khoury T, Skitzki JJ, Gollnick SO, Evans SS. PMID: 26599402; PMCID: PMC4657935.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    40. Antitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10. Eur J Immunol. 2015 Apr; 45(4):999-1009. Tao H, Lu L, Xia Y, Dai F, Wang Y, Bao Y, Lundy SK, Ito F, Pan Q, Zhang X, Zheng F, Shu G, Fang B, Jiang J, Xia J, Huang S, Li Q, Chang AE. PMID: 25545618; PMCID: PMC4414939.
      View in: PubMed   Mentions: 65     Fields:    Translation:AnimalsCells
    41. Cancer immunotherapy: current status and future directions. Surg Oncol Clin N Am. 2013 Oct; 22(4):765-83. Ito F, Chang AE. PMID: 24012398.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    42. Water: a simple solution for tumor spillage. Ann Surg Oncol. 2011 Aug; 18(8):2357-63. Ito F, Camoriano M, Seshadri M, Evans SS, Kane JM, Skitzki JJ. PMID: 21301970; PMCID: PMC5778406.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    43. Hilar cholangiocarcinoma: current management. Ann Surg. 2009 Aug; 250(2):210-8. Ito F, Cho CS, Rikkers LF, Weber SM. PMID: 19638920.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    44. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008 Aug; 248(2):273-9. Ito F, Agni R, Rettammel RJ, Been MJ, Cho CS, Mahvi DM, Rikkers LF, Weber SM. PMID: 18650638.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    45. Transabdominal preperitoneal robotic inguinal hernia repair. J Laparoendosc Adv Surg Tech A. 2008 Jun; 18(3):397-9. Ito F, Jarrard D, Gould JC. PMID: 18503373.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg. 2007 Jun; 245(6):959-63. Ito F, Sippel R, Lederman J, Chen H. PMID: 17522522; PMCID: PMC1876969.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    47. Robotic foregut surgery. Int J Med Robot. 2006 Dec; 2(4):287-92. Ito F, Gould JC. PMID: 17520645.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Anti-CD137 monoclonal antibody administration augments the antitumor efficacy of dendritic cell-based vaccines. Cancer Res. 2004 Nov 15; 64(22):8411-9. Ito F, Li Q, Shreiner AB, Okuyama R, Jure-Kunkel MN, Teitz-Tennenbaum S, Chang AE. PMID: 15548712.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    49. Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control the efficiency of cytotoxic T cell priming. Microbiol Immunol. 2004; 48(3):211-9. Nakamura I, Kajino K, Bamba H, Itoh F, Takikita M, Ogasawara K. PMID: 15031535.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    50. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Cancer Res. 2003 Dec 01; 63(23):8466-75. Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE. PMID: 14679011.
      View in: PubMed   Mentions: 72     Fields:    Translation:AnimalsCells
    51. Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapy. Cancer Res. 2003 May 15; 63(10):2546-52. Li Q, Carr A, Ito F, Teitz-Tennenbaum S, Chang AE. PMID: 12750278.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    52. Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine model. J Immunother. 2003 May-Jun; 26(3):222-33. Ito F, Carr A, Svensson H, Yu J, Chang AE, Li Q. PMID: 12806276.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    Fumito's Networks
    Concepts (234)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-18-gb39b692b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.